Unknown NA INTERVENTIONAL 1-arm NCT05028023

Tracheal Dilatation in Pediatric Patients With Acquired Tracheal Stenosis, and the Effects of Apneic Oxygenation

Effects of Apneic Oxygenation in Regional Cerebral Oxygen Saturation rSO2 During Tracheal Dilatation Procedures in Pediatric Patients (With Acquired Tracheal Stenosis). Innovation and Safety of the Technique

Sponsor: Aristotle University Of Thessaloniki

Conditions Apnea+Hypopnea Cerebral Hypoxia Igel Pediatric Respiratory Diseases Tracheal Dilatation Tracheal Stenosis

Interventions Apneic oxygenation - supplemental high flow oxygen administration by an apneic way

Updated 5 times since 2021 Last updated: Aug 24, 2021 Started: Oct 21, 2020 Primary completion: Jan 31, 2022 Completion: Aug 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05028023, this NA trial focuses on Apnea+Hypopnea and Cerebral Hypoxia and remains ongoing. Sponsored by Aristotle University Of Thessaloniki, it has been updated 5 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Sep 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Sep 2021 — Sep 2023 [monthly]

Recruiting NA

First recorded

Oct 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aristotle University Of Thessaloniki

Data source: Aristotle University Of Thessaloniki

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Thessaloniki, Greece